Option B is correct because the question describes the process of transferring genes into animals to produce proteins on a large scale in milk or blood, which is defined as Molecular pharming. The context supports this by listing the production of biopharmaceuticals as an application of animal cell culture. Option D, Hybridoma technology, is incorrect because the provided text (Table 8.3) specifically links Hybridoma cells to the production of Monoclonal antibodies, not the general production of proteins in milk or blood described in the question.